Celsion (NASDAQ: CLSN) reported data from a preclinical study confirming that the Company's TheraSilence™ technology platform can safely and effectively ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE